JC
KITE

Jetstream Capital’s Kite Pharma, Inc. KITE Stock Holding History

Jetstream Capital’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$726K Buy
+13,000
New +$724K 9.72% 3

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jetstream Capital's KITE Position: Q3 2016 in Review

Jetstream Capital opened a new position in Kite Pharma, Inc. (KITE) in Q3 2016: 13,000 shares worth $726K. The stake represents 9.72% of the portfolio and ranks #3 among its holdings.

195 funds tracked by Wall St. Rank hold KITE as of Q3 2016.

  • Jetstream Capital held 13,000 shares of Kite Pharma, Inc. worth $726K as of Q3 2016.
  • Kite Pharma, Inc. was a new Jetstream Capital position in Q3 2016.
  • Kite Pharma, Inc. made up 9.72% of Jetstream Capital's portfolio in Q3 2016, its #3 holding.
  • 195 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2016.

Based on Jetstream Capital's 13F filing for Q3 2016, filed 14 Nov 2016.